Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction

Basic Research in Cardiology

Volumn 112, Issue 2, 2017, Pages

  Guo, Yiru ^a   Wysoczynski, Marcin ^a   Nong, Yibing ^a   Tomlin, Alex ^a   Zhu, Xiaoping ^a   Gumpert, Anna M ^a   Nasr, Marjan ^a   Muthusamy, Senthikumar ^a   Li, Hong ^a   Book, Michael ^a   Khan, Abdur ^a   Hong, Kyung U ^a   Li, Qianhong ^a   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cell therapy; Ischemic cardiomyopathy; Progenitor cells; Stem cells

Indexed keywords

COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MESENCHYMAL CELL; CELL DIFFERENTIATION; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; ENGRAFTMENT; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MESENCHYME CELL; MOUSE; MOUSE MODEL; NONHUMAN; PILOT STUDY; RETREATMENT; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CYTOLOGY; DISEASE MODEL; ECHOCARDIOGRAPHY; FEMALE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PROCEDURES; RANDOMIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RANDOM ALLOCATION;

EID: 85013173182     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-017-0606-5     Document Type: Article

References (37)

1. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S (2003) Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107:2134–2139. doi:10.1161/01.CIR.0000062649.63838.C9
2. Al Kindi A, Ge Y, Shum-Tim D, Chiu RC (2008) Cellular cardiomyoplasty: routes of cell delivery and retention. Front Biosci 13:2421–2434
3. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108:863–868. doi:10.1161/01.CIR.0000084828.50310.6A
4. + cells after intracoronary injection. Stem Cells 24:333–336. doi:10.1634/stemcells.2005-0201
5. Bolli R, Patel BS, Jeroudi MO, Li XY, Triana JF, Lai EK, McCay PB (1990) Iron-mediated radical reactions upon reperfusion contribute to myocardial “stunning”. Am J Physiol 259:H1901–H1911
6. Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A, Jneid H, Rota M, Leri A, Kajstura J (2013) Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128:122–131. doi:10.1161/CIRCULATIONAHA.112.001075
7. Cai C, Guo Y, Teng L, Nong Y, Tan M, Book MJ, Zhu X, Wang XL, Du J, Wu WJ, Xie W, Hong KU, Li Q, Bolli R (2015) Preconditioning human cardiac stem cells with an HO-1 inducer exerts beneficial effects after cell transplantation in the infarcted murine heart. Stem Cells 33:3596–3607. doi:10.1002/stem.2198
8. Cheng K, Li TS, Malliaras K, Davis DR, Zhang Y, Marban E (2010) Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 106:1570–1581. doi:10.1161/CIRCRESAHA.109.212589
9. Dawn B, Guo Y, Rezazadeh A, Huang Y, Stein AB, Hunt G, Tiwari S, Varma J, Gu Y, Prabhu SD, Kajstura J, Anversa P, Ildstad ST, Bolli R (2006) Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 98:1098–1105. doi:10.1161/01.RES.0000218454.76784.66
10. Feldman MD, Erikson JM, Mao Y, Korcarz CE, Lang RM, Freeman GL (2000) Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals. Am J Physiol Heart Circ Physiol 279:H1698–H1707
11. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, Bolli R (1999) The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96:11507–11512
12. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R (1998) Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 275:H1375–H1387
13. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, Ganser A, Knapp WH, Drexler H (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198–2202. doi:10.1161/01.CIR.0000163546.27639.AA
14. Hong KU, Guo Y, Li QH, Cao P, Al-Maqtari T, Vajravelu BN, Du J, Book MJ, Zhu X, Nong Y, Bhatnagar A, Bolli R (2014) c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One 9:e96725. doi:10.1371/journal.pone.0096725
15. Hong KU, Li QH, Guo Y, Patton NS, Moktar A, Bhatnagar A, Bolli R (2013) A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol 108:346. doi:10.1007/s00395-013-0346-0
16. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, Yeung AC, Johnstone BH, Yock PG, March KL (2005) Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112:I150–I156. doi:10.1161/CIRCULATIONAHA.104.526749
17. Keith MC, Bolli R (2015) “String theory” of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ Res 116:1216–1230. doi:10.1161/CIRCRESAHA.116.305557
18. Kishore R, Khan M (2016) More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ Res 118:330–343. doi:10.1161/CIRCRESAHA.115.307654
19. Li Q, Guo Y, Ou Q, Chen N, Wu WJ, Yuan F, O’Brien E, Wang T, Luo L, Hunt GN, Zhu X, Bolli R (2011) Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol 106:849–864. doi:10.1007/s00395-011-0180-1
20. Li Q, Guo Y, Ou Q, Cui C, Wu WJ, Tan W, Zhu X, Lanceta LB, Sanganalmath SK, Dawn B, Shinmura K, Rokosh GD, Wang S, Bolli R (2009) Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway. Circulation 120:1222–1230. doi:10.1161/CIRCULATIONAHA.108.778688
21. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, Zheng Y, Huang S, Han J, Bolli R (2000) PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279:H1679–H1689
22. Li XY, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R (1993) Demonstration of free radical generation in the “stunned” myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest 92:1025–1041. doi:10.1172/JCI116608
23. Panda NC, Zuckerman ST, Mesubi OO, Rosenbaum DS, Penn MS, Donahue JK, Alsberg E, Laurita KR (2014) Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel. J Interv Card Electrophysiol 41:117–127. doi:10.1007/s10840-014-9940-9
24. Robey TE, Saiget MK, Reinecke H, Murry CE (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45:567–581. doi:10.1016/j.yjmcc.2008.03.009
25. Sanganalmath SK, Bolli R (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113:810–834. doi:10.1161/CIRCRESAHA.113.300219
26. Takano H, Bolli R, Black RG Jr, Kodani E, Tang XL, Yang Z, Bhattacharya S, Auchampach JA (2001) A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88:520–528
27. Tang XL, Li Q, Rokosh G, Sanganalmath S, Chen N, Ou Q, Stowers H, Hunt G, Bolli R (2016) Long-term outcome of administration of c-kitPOS cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res 118:1091–1105. doi:10.1161/CIRCRESAHA.115.307647
28. Tang XL, Li Q, Rokosh G, Sanganalmath SK, Chen N, Ou Q, Stowers H, Hunt G, Bolli R (2016) Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res 118:1091–1105. doi:10.1161/CIRCRESAHA.115.307647
29. Tang XL, Qiu Y, Park SW, Sun JZ, Kalya A, Bolli R (1996) Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79:424–434
30. Tang XL, Rokosh G, Sanganalmath SK, Tokita Y, Keith MC, Shirk G, Stowers H, Hunt GN, Wu W, Dawn B, Bolli R (2015) Effects of intracoronary infusion of escalating doses of cardiac stem cells in rats with acute myocardial infarction. Circ Heart Fail 8:757–765. doi:10.1161/CIRCHEARTFAILURE.115.002210
31. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, Hunt G, Leri A, Kajstura J, Tiwari S, Shirk G, Anversa P, Bolli R (2010) Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121:293–305. doi:10.1161/CIRCULATIONAHA.109.871905
32. Terrovitis J, Lautamaki R, Bonios M, Fox J, Engles JM, Yu J, Leppo MK, Pomper MG, Wahl RL, Seidel J, Tsui BM, Bengel FM, Abraham MR, Marban E (2009) Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54:1619–1626. doi:10.1016/j.jacc.2009.04.097
33. Tokita Y, Tang XL, Li Q, Wysoczynski M, Hong KU, Nakamura S, Wu WJ, Xie W, Li D, Hunt G, Ou Q, Stowers H, Bolli R (2016) Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ Res 119:635–651. doi:10.1161/CIRCRESAHA.116.308937
34. Wysoczynski M, Dassanayaka S, Zafir A, Ghafghazi S, Long BW, Noble C, DeMartino AM, Brittian KR, Bolli R, Jones SP (2016) A new method to stabilize c-kit expression in reparative cardiac mesenchymal cells. Front Cell Dev Biol 4:78. doi:10.3389/fcell.2016.00078
35. Wysoczynski M, Guo Y, Moore J, Muthusamy M, Li Q, Nasr M, Li H, Nong Y, Wu W, Tomlin A, Zhu X, Hunt G, Gumpert A, Book M, Khan A, Tang XL, Bolli R (2016) A new population of cardiac mesenchymal cells isolated on the basis of adherence: phenotype and reparative properties. J Am Coll Cardiol (2016) (in press)
36. Yu J, Du KT, Fang Q, Gu Y, Mihardja SS, Sievers RE, Wu JC, Lee RJ (2010) The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 31:7012–7020. doi:10.1016/j.biomaterials.2010.05.078
37. Zhu WX, Myers ML, Hartley CJ, Roberts R, Bolli R (1986) Validation of a single crystal for measurement of transmural and epicardial thickening. Am J Physiol 251:H1045–H1055